Colombia Cancer Costs Surge 37% as Drug Prices and Patient Numbers Rise

Cancer-related costs in Colombia rose over 37% from 2022 to 2025, driven by high-cost drugs and increasing patient volumes, with annual state expenditure estimated between $12 trillion and $23 trillion. The exact breakdown of cost drivers and the sustainability of the health system remain uncertain. This fiscal pressure could affect Colombia's public finances and health policy priorities.